These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11503841)

  • 21. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.
    Vexiau P; Mavros P; Krishnarajah G; Lyu R; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():16-24. PubMed ID: 18435670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mortality risk with sulphonylureas compared to metformin.
    Holden SE; Currie CJ
    Diabetes Obes Metab; 2014 Oct; 16(10):885-90. PubMed ID: 24533964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
    Ritsinger V; Malmberg K; Mårtensson A; Rydén L; Wedel H; Norhammar A
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):627-33. PubMed ID: 24831989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
    André P
    Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
    [No Abstract]   [Full Text] [Related]  

  • 25. Lessons from UK prospective diabetes study.
    Turner RC; Holman RR
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S151-7. PubMed ID: 8529508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. United Kingdom prospective diabetes study (UKPDS): what now or so what?
    Leslie RD
    Diabetes Metab Res Rev; 1999; 15(1):65-71. PubMed ID: 10398549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controversies in management of diabetes in patients with coronary heart disease.
    Abdella NA
    Med Princ Pract; 2002; 11 Suppl 2():69-74. PubMed ID: 12444313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cardiovascular effects of metformin: further reasons to consider an old drug as a cornerstone in the therapy of type 2 diabetes mellitus.
    Anfossi G; Russo I; Bonomo K; Trovati M
    Curr Vasc Pharmacol; 2010 May; 8(3):327-37. PubMed ID: 19485923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The UK Prospective Diabetes Study. UK Prospective Diabetes Study Group.
    Turner RC; Holman RR
    Ann Med; 1996 Oct; 28(5):439-44. PubMed ID: 8949976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis.
    Campbell JM; Bellman SM; Stephenson MD; Lisy K
    Ageing Res Rev; 2017 Nov; 40():31-44. PubMed ID: 28802803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of metformin on haemostasis and vascular function in man.
    Grant PJ
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S44-52. PubMed ID: 14502100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [++UKPDS Study. Metformin in obese patients with Type 2 diabetes (UKPDS 340].
    Janka HU
    Internist (Berl); 2000 Jul; 41(7):688-9. PubMed ID: 10929259
    [No Abstract]   [Full Text] [Related]  

  • 33. Do effects on blood pressure contribute to improved clinical outcomes with metformin?
    Schäfers RF
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S62-70. PubMed ID: 14502102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of oral hypoglycaemic agents on dyslipidaemia in Nigerian patients with newly diagnosed non-insulin dependent diabetes mellitus--a prospective study.
    Agboola-Abu CF; Ohwovoriole AE; Akinlade KS
    West Afr J Med; 2000; 19(2):126-31. PubMed ID: 11070748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 14-Year risk of all-cause mortality according to hypoglycaemic drug exposure in a general population.
    Bérard E; Bongard V; Dallongeville J; Arveiler D; Cottel D; Wagner A; Ruidavets JB; Ferrières J
    PLoS One; 2014; 9(4):e95671. PubMed ID: 24752580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lessons from the "United Kingdom Prospective Diabetes Study"].
    Scheen AJ; Lefèbvre PJ
    Rev Med Liege; 1998 Sep; 53(9):576-8. PubMed ID: 9834682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The management of non-insulin-dependent diabetes during pregnancy.
    Coetzee EJ; Jackson WP
    Diabetes Res Clin Pract; 1985-1986 Feb; 1(5):281-7. PubMed ID: 3939118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The UKPDS after one year. Diabetological realities and desiderata. United Kingdom Prospective Diabetes Study].
    Mehnert H
    Dtsch Med Wochenschr; 1999 Sep; 124(36):1021. PubMed ID: 10506838
    [No Abstract]   [Full Text] [Related]  

  • 39. United Kingdom Prospective Diabetes Study (UKPDS). Effects of glucose and blood pressure control on complications of type 2 diabetes mellitus.
    Nasr CE; Hoogwerf BJ; Faiman C; Reddy SS
    Cleve Clin J Med; 1999 Apr; 66(4):247-53. PubMed ID: 10199061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the UKPDS--an overview.
    Home PD
    Diabet Med; 2008 Aug; 25 Suppl 2():2-8. PubMed ID: 18717971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.